ROIV

Roivant Sciences Ltd

Stock NASDAQ – Stock Market Prices, News & Analysis

Roivant Sciences Ltd is an innovative biopharmaceutical company focused on leveraging technology and data analysis for drug development.

$ 28.33
2.64 %

Roivant Sciences Ltd

$ 28.33
2.64 %
ROIV

Roivant Sciences Ltd is an innovative biopharmaceutical company focused on leveraging technology and data analysis for drug development.

Price history of Roivant Sciences Ltd
Price history of Roivant Sciences Ltd

Performance & Momentum

6 Months 75.20 %
1 Year 183.02 %
3 Years 282.84 %
5 Years 188.20 %

Strategic Analysis

Roivant Sciences Ltd • 2026

Roivant Sciences stands out with its integrated biotechnology and big data analytics model to accelerate the discovery and development of innovative drugs. This technological approach allows it to quickly target promising therapeutic niches while optimizing the efficiency of its research programs.

Strengths
  • Advanced integration of data science in biopharmaceutical R&D
  • Diversified portfolio of projects focused on unmet medical needs
  • Dynamic positioning in the U.S. innovative healthcare market
Weaknesses
  • Significant dependence on clinical and regulatory success
  • Recent lack of major announcements that could support momentum
Momentum

The momentum is extremely positive, supported by very strong stock performance across all recent periods, reflecting investor confidence in its innovative strategy despite a lack of recent news. This dynamic suggests growing interest in its medium-term prospects.

Analysis performed 1 month ago

Similar stocks to Roivant Sciences Ltd

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone